Tempest Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent
Tempest Therapeutics, Inc. (TPST) reported Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent of -0.94% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsOther · last filed 2016-02-26
- Tempest Therapeutics, Inc. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2015 was -0.94%.
- Tempest Therapeutics, Inc. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2014 was -0.31%.
- Tempest Therapeutics, Inc. effective income tax rate reconciliation, tax credit, other, percent for fiscal 2013 was -0.17%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent 12 month as first filed |
|---|---|---|
| 2015-12-31 | -0.94% 10-K · filed 2016-02-26 | |
| 2014-12-31 | -0.31% 10-K · filed 2016-02-26 | -0.03% 10-K · filed 2015-03-16 |
| 2013-12-31 | -0.17% 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |